SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bayer to Present New Finerenone and Asundexian Data

Bayer says it will present finerenone data across heart failure and chronic kidney disease, plus asundexian data from OCEANIC-STROKE.

AG

Related stories